Skip to main content

DCF Advisers, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1802493 MOUNT PLEASANT, SC

Position in IONS

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$4,205,040
-$3,943,290 QoQ
Shares Held
56,000
-45.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$45,255
PutShares
1,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DCF Advisers, LLC holds $55,922,160 across 20 Biotechnology names. IONS ranks #5 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 IONS
Ionis Pharmaceuticals Inc
This page
56,000 $4,205,040

All Filings in IONS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,205,040 56,000
2025-12-31 $8,148,330 103,000
2025-09-30 $7,092,378 108,413
2025-06-30 $3,625,042 91,750
2025-03-31 $45,255 1,500
2025-03-31 $2,866,150 95,000
2024-12-31 $2,897,554 82,882
2024-12-31 $69,920 2,000
2024-09-30 $1,582,370 39,500
2024-09-30 $160,240 4,000
2024-06-30 $1,096,180 23,000
2024-06-30 $23,830 500